Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles (eBook, ePUB)
Redaktion: Cassee, Flemming R.; Newby, David E.; Mills, Nicholas L.
Alle Infos zum eBook verschenken
Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles (eBook, ePUB)
Redaktion: Cassee, Flemming R.; Newby, David E.; Mills, Nicholas L.
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Hier können Sie sich einloggen
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 11.29MB
- Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles (eBook, PDF)160,99 €
- Y. Robert LiCardiovascular Diseases (eBook, ePUB)100,99 €
- A Textbook of Modern Toxicology (eBook, ePUB)101,99 €
- David A. CremersHandbook of Laser-Induced Breakdown Spectroscopy (eBook, ePUB)119,99 €
- Patrick K. JjembaPharma-Ecology (eBook, ePUB)167,99 €
- Laser Induced Breakdown Spectroscopy (LIBS) (eBook, ePUB)330,99 €
- Anshul NigamEnvironmental Analysis Laboratory Handbook (eBook, ePUB)193,99 €
-
-
-
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
- Produktdetails
- Verlag: John Wiley & Sons
- Seitenzahl: 604
- Erscheinungstermin: 29. März 2011
- Englisch
- ISBN-13: 9780470922774
- Artikelnr.: 37300442
- Verlag: John Wiley & Sons
- Seitenzahl: 604
- Erscheinungstermin: 29. März 2011
- Englisch
- ISBN-13: 9780470922774
- Artikelnr.: 37300442
CHAPTER 1 OVERVIEW (Flemming R. Cassee and Morton Lippmann). CHAPTER 2
ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION
(Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth). CHAPTER 3 CHRONIC
EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan,
Joel Kaufman, and Gerard Hoek). PART II. EXPOSURE. CHAPTER 4 PARTICLE
CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach). CHAPTER 5
EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef
Cyrys, H.-Erich Wichmann, and Jeroen de Hartog). CHAPTER 6 FROM EXPOSURE TO
DOSE (Werner Hofmann and Bahman Asgharian). CHAPTER 7 TRANSLOCATION OF
INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid,
Manuela Semmler-Behnke, and Günter Oberdörster). CHAPTER 8 ROLE OF CHEMICAL
COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew
J. Ghio and Yuh-Chin T. Huang). PART III. METHODOLOGY. CHAPTER 9 IN VITRO
STUDIES (Per E. Schwarze and Gerrit M. Alink). CHAPTER 10 EXPERIMENTAL
STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L.
Costa). CHAPTER 11 HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W.
Frampton, and Anders Blomberg). CHAPTER 12 PANEL STUDIES (Joel Schwartz).
PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. A.
ATHEROGENESIS. CHAPTER 13 PARTICULATES AND OXIDATIVE STRESS (Steffen Loft,
Roel P.F. Schins, and Peter Møller). CHAPTER 14 ROLE OF INFLAMMATION IN THE
ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David
Newby). CHAPTER 15 INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR
POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
(Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler). CHAPTER
16 INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara
Hoffmann and Nino Künzli). CHAPTER 17 EFFECTS OF NANOPARTICLES ON THE
PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl,
and Dennis W. Wilson). CHAPTER 18 PARTICULATE MATTER, HYPERTENSION, AND THE
METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan). CHAPTER 19
PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R.
Miller). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. B.
VASCULAR DYSFUNCTION. PART IV. PARTICLES AND CARDIOVASCULAR DISEASE:
MECHANISMS. C. THROMBOSIS. CHAPTER 20 PARTICLES, COAGULATION, AND
THROMBOSIS (Evren Kilinç, Goran Rude~, Henri M.H. Spronk, Abderrahim
Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts). CHAPTER
21 PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and
Xiaohua Xu). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. D.
ARRHYTHMIA. CHAPTER 22 PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna
Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz). CHAPTER 23 AIR
POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend). PART
V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY. CHAPTER 24 RISK ASSESSMENT
(Robert L. Maynard and Jon G. Ayres). CHAPTER 25 ENVIRONMENTAL REGULATION
OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and
Sophie Punte). CHAPTER 26 FROM AMBIENT ULTRAFINE PARTICLES TO
NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).
INDEX.
CHAPTER 1 OVERVIEW (Flemming R. Cassee and Morton Lippmann). CHAPTER 2
ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION
(Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth). CHAPTER 3 CHRONIC
EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan,
Joel Kaufman, and Gerard Hoek). PART II. EXPOSURE. CHAPTER 4 PARTICLE
CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach). CHAPTER 5
EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef
Cyrys, H.-Erich Wichmann, and Jeroen de Hartog). CHAPTER 6 FROM EXPOSURE TO
DOSE (Werner Hofmann and Bahman Asgharian). CHAPTER 7 TRANSLOCATION OF
INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid,
Manuela Semmler-Behnke, and Günter Oberdörster). CHAPTER 8 ROLE OF CHEMICAL
COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew
J. Ghio and Yuh-Chin T. Huang). PART III. METHODOLOGY. CHAPTER 9 IN VITRO
STUDIES (Per E. Schwarze and Gerrit M. Alink). CHAPTER 10 EXPERIMENTAL
STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L.
Costa). CHAPTER 11 HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W.
Frampton, and Anders Blomberg). CHAPTER 12 PANEL STUDIES (Joel Schwartz).
PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. A.
ATHEROGENESIS. CHAPTER 13 PARTICULATES AND OXIDATIVE STRESS (Steffen Loft,
Roel P.F. Schins, and Peter Møller). CHAPTER 14 ROLE OF INFLAMMATION IN THE
ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David
Newby). CHAPTER 15 INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR
POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
(Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler). CHAPTER
16 INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara
Hoffmann and Nino Künzli). CHAPTER 17 EFFECTS OF NANOPARTICLES ON THE
PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl,
and Dennis W. Wilson). CHAPTER 18 PARTICULATE MATTER, HYPERTENSION, AND THE
METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan). CHAPTER 19
PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R.
Miller). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. B.
VASCULAR DYSFUNCTION. PART IV. PARTICLES AND CARDIOVASCULAR DISEASE:
MECHANISMS. C. THROMBOSIS. CHAPTER 20 PARTICLES, COAGULATION, AND
THROMBOSIS (Evren Kilinç, Goran Rude~, Henri M.H. Spronk, Abderrahim
Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts). CHAPTER
21 PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and
Xiaohua Xu). PART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS. D.
ARRHYTHMIA. CHAPTER 22 PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna
Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz). CHAPTER 23 AIR
POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend). PART
V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY. CHAPTER 24 RISK ASSESSMENT
(Robert L. Maynard and Jon G. Ayres). CHAPTER 25 ENVIRONMENTAL REGULATION
OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and
Sophie Punte). CHAPTER 26 FROM AMBIENT ULTRAFINE PARTICLES TO
NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).
INDEX.